• レポートコード:STR-DC034 • 出版社/出版日:Straits Research / 2019年11月28日 • レポート形態:英文、PDF、114ページ • 納品方法:Eメール(受注後2-3日) • 産業分類:製薬 |
Single User(1名様用、印刷不可) | ¥629,000 (USD4,250) | ▷ お問い合わせ |
Multi User(5名様用) | ¥836,200 (USD5,650) | ▷ お問い合わせ |
Enterprise Price(法人閲覧用) | ¥1,073,000 (USD7,250) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査レポートでは、フェニルケトン尿症の世界市場について調査・分析し、調査手法、市場概要、製品種類別(医薬品、栄養補助食品)分析、投与経路別(経口経路、非経口経路)分析、流通チャンネル別(ドラッグストア、オンライン薬局、小児科医院)分析、地域別分析、企業概要などを含め次の構成でお届け致します。 ・イントロダクション ・調査手法 ・市場概要 ・フェニルケトン尿症の世界市場:製品種類別(医薬品、栄養補助食品) ・フェニルケトン尿症の世界市場:投与経路別(経口経路、非経口経路) ・フェニルケトン尿症の世界市場:流通チャンネル別(ドラッグストア、オンライン薬局、小児科医院) ・フェニルケトン尿症の世界市場:地域別 ・企業概要 |
Phenylketonuria market accounted for around USD 92654.3 million in 2018 and is expected to grow at a CAGR of 34.6% during the forecast period, 2019–2026.
Phenylketonuria is an inborn genetic disorder, in which decreased metabolism of the amino acid phenylalanine. It is a rare genetic disorder that increases the level of phenylalanine in the blood and causes problems throughout the body. Phenylketonuria is major causes of seizures, intellectual disability, mental disorder, and behavioral problems.
High prevalence of phenylketonuria across the globe is driving the growth of market. For instance, according to the Boston Children’s Hospital, around one in 15,000 babies are born with PKU in the United States every year.
Growing number of pipeline of product for treatment of phenylketonuria is boosting the growth of market. For instance, CNSA-001 developed by Censa Pharmaceuticals, Inc. is under Phase 2.
Segmental Insights
Phenylketonuria market is segmented by product type, rout of administration and distribution channel.
On the basis of product type, the market is segmented into drugs and dietary supplement.
Drug is further segmented into kuvan and biopten.
Based on rout of administration, the market is segmented into oral route and parenteral route.
Oral route is further segmented into tablets & capsules, syrups and powder.
Parenteral route is further segmented into intravenous and subcutaneous. Oral route is expected to hold major market share owing to dose flexibility and acceptable size and volume.
On the distribution channel, the market is segmented into hospital pharmacies, drug stores, online pharmacies and pediatric clinics. Hospital pharmacies is expected to hold major market share over the forecast period.
Regional Insights
Geographically, the phenylketonuria market is segmented into four North America, Europe, Asia Pacific, and Latin America and the Middle East & Africa (LAMEA).
North America is dominating the market and expected to grow over forecast period.
According to the CanPKU in U.S. Phenylketonuria test is recommended as the first condition widely tested for through newborn screening. Increasing research and development and development for development of advanced treatment is propelling the growth of market. For instance, May 2018, U.S. Food and Drug Administration approved Palynziq (pegvaliase-pqpz) for treatment of phenylketonuria.
Europe accounted for second largest share for phenylketonuria market. Increasing number incidences of phenylketonuria in several European countries is boosting the growth of market. For instance, according to the NHS England, during 2015–2016, it was estimated approximately, 1 per 10,000/14,000 diagnosed with phenylketonuria. Furthermore, Different nonprofit organization work for management of phenylketonuria is fueling the growth of market. For instance, – European Society for Phenylketonuria and Allied Disorders, has been published in the Orphanet Journal of Rare Diseases for increasing awareness of phenylketonuria.
Key Players
Some of the key players in the phenylketonuria market include ambrooke Therapeutics, Daiichi Sankyo Company Limited, American Gene Technologies International, Inc., Danone Nutricia, Dimension Therapeutics, Inc., Synthetic Biologics, Inc., SOM Innovation Biotech SL, Codexis, Inc., BioMarin Pharmaceutical, Inc., and Erytech Pharma SA, among others.
TABLE OF CONTENT
1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Market Overview
3.1 Report Segmentation & Scope
3.2 Value Chain Analysis: Phenylketonuria Market
3.3 Key Market Trends
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitution
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
4. By Product Type
4.1 Introduction
4.1.1 Market Size & Forecast (Value)
4.2 Drugs
4.2.1 Kuvan
4.2.2 Biopten
4.3 Dietary Supplement
5. By Rout of Administration
5.1 Introduction
5.1.1 Market Size & Forecast (Value)
5.2 Oral Route
5.2.1 Tablets and Capsules
5.2.2 Syrups
5.2.3 Powder
5.3 Parenteral Route
5.3.1 Intravenous
5.3.2 Subcutaneous
6. By Distribution Channel
6.1 Introduction
6.1.1 Market Size & Forecast (Value)
6.2 Drug Stores
6.3 Online Pharmacies
6.4 Pediatric Clinics
7. By Regional Overview
7.1 Introduction
7.1.1 Market Size & Forecast (Value)
7.2 America
7.2.1 North America
7.2.1.1 U.S.
7.2.1.1.1 By Product Type
7.2.1.1.2 By Rout of Administration
7.2.1.2 Canada
7.2.1.2.1 By Product Type
7.2.1.2.2 By Rout of Administration
7.2.1.3 Mexico
7.2.1.3.1 By Product Type
7.2.1.3.2 By Rout of Administration
7.2.2 South America
7.2.2.1 By Product Type
7.2.2.2 By Rout of Administration
7.3 Europe
7.3.1 Market Size & Forecast (Value)
7.3.2 Western Europe
7.3.2.1 Germany
7.3.2.1.1 By Product Type
8.3.2.1.2 By Rout of Administration
7.3.2.2 France
7.3.2.2.1 By Product Type
7.3.2.2.2 By Rout of Administration
7.3.2.3 U.K
7.3.2.3.1 By Product Type
7.3.2.3.2 By Rout of Administration
7.3.2.4 Italy
7.3.2.4.1 By Product Type
7.3.2.4.2 By Rout of Administration
7.3.2.5 Spain
7.3.2.5.1 By Product Type
7.3.2.5.2 By Rout of Administration
7.3.2.6 Rest of Western Europe
7.3.2.6.1 By Product Type
7.3.2.6.2 By Rout of Administration
7.3.3 Eastern Europe
7.4 Asia Pacific
7.4.1 Market Size & Forecast (Value)
7.4.2 China
7.4.2.1 By Product Type
7.4.2.2 By Rout of Administration
7.4.3 India
7.4.3.1 By Product Type
7.4.3.2 By Rout of Administration
7.4.4 Japan
7.4.4.1 By Product Type
7.4.4.2 By Rout of Administration
7.4.5 South Korea
7.4.5.1 By Product Type
7.4.5.2 By Rout of Administration
7.4.6 Australia
7.4.6.1 By Product Type
7.4.6.2 By Rout of Administration
7.4.7 Rest of Asia-Pacific
7.4.7.1 By Product Type
7.4.7.2 By Rout of Administration
7.5 Middle East & Africa
7.5.1 Market Size & Forecast (Value)
7.5.2 The Middle East
7.5.2.1 South Africa
7.5.2.1.1 By Product Type
7.5.2.1.2 By Rout of Administration
7.5.2.2 UAE
7.5.2.2.1 By Product Type
7.5.2.2.2 By Rout of Administration
7.5.2.3 Qatar
7.5.2.3.1 By Product Type
7.5.2.3.2 By Rout of Administration
7.5.2.4 Rest of Middle East
7.5.2.4.1 By Product Type
7.5.2.4 2 By Rout of Administration
7.5.3 Africa
7.5.3.1 By Product Type
7.5.3.2 By Rout of Administration
8. Company Profile
8.1 Ambrooke Therapeutics
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Recent Developments
8.1.4 Product Portfolio
8.2 Daiichi Sankyo Company Limited
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Recent Developments
8.2.4 Product Portfolio
8.3 American Gene Technologies International, Inc.
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Recent Developments
8.3.4 Product Portfolio
8.4 Koninklijke Philips
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Recent Developments
8.4.4 Product Portfolio
8.5 Dimension Therapeutics, Inc.
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Recent Developments
8.5.4 Product Portfolio
8.6 Synthetic Biologics, Inc.
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Recent Developments
8.6.4 Product Portfolio
8.7 SOM Innovation Biotech SL
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Recent Developments
8.7.4 Product Portfolio
8.8 Codexis, Inc.
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Recent Developments
8.8.4 Product Portfolio
8.9 BioMarin Pharmaceutical, Inc.
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Recent Developments
8.9.4 Product Portfolio
8.10 Erytech Pharma SA
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Recent Developments
8.10.4 Product Portfolio
TABLE 1 Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 2 Drugs Market Share, By Region, 2016-2026 ($ Million)
TABLE 3 Dietary Supplement Market Share, By Region, 2016-2026, ($ Million)
TABLE 4 Phenylketonuria Market Share, By Rout of Administration 2016-2026 ($Million)
TABLE 5 Parenteral Route Market Share, By Region, 2016-2026 ($ Million)
TABLE 6 Oral Route Market Share, By Region, 2016-2026 ($ Million)
TABLE 7 Phenylketonuria Market Share Value, 2016-2026 ($Million)
TABLE 8 Phenylketonuria Market Share By Region, 2016-2026 ($ Million)
TABLE 9 America Phenylketonuria Market Share Value, By Country, 2016-2026 ($Million)
TABLE 10 America Phenylketonuria Market Share value, By Product Type, 2016-2026 ($Million)
TABLE 11 America Phenylketonuria Market Share value, By Rout of Administration, 2016-2026 ($Million)
TABLE 12 U.S. Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 13 U.S. Phenylketonuria Market Share, By Rout of Administration, 2016-2026 ($Million)
TABLE 14 Canada Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 15 Canada Phenylketonuria Market Share, By Rout of Administration 2016-2026 ($Million)
TABLE 16 Mexico Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 17 Mexico Phenylketonuria Market Share, By Rout of Administration 2016-2026 ($Million)
TABLE 18 South America Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 19 South America Phenylketonuria Market Share, By Rout of Administration 2016-2026 ($Million)
TABLE 20 Europe Phenylketonuria Market Share Value, By Region, 2016-2026 ($Million)
TABLE 21 Europe Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 22 Europe Phenylketonuria Market Share, By Rout of Administration 2016-2026 ($Million)
TABLE 23 Western Europe Phenylketonuria Market Share Value, By Country, 2016-2026 ($Million)
TABLE 24 Western Europe Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 25 Western Europe Phenylketonuria Market Share, By Rout of Administration 2016-2026 ($Million)
TABLE 26 Germany Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 27 Germany Phenylketonuria Market Share, By Rout of Administration 2016-2026 ($Million)
TABLE 28 France Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 29 France Phenylketonuria Market Share, By Rout of Administration 2016-2026 ($Million)
TABLE 30 UK Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 31 UK Phenylketonuria Market Share, By Rout of Administration 2016-2026 ($Million)
TABLE 32 Italy Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 33 Italy Phenylketonuria Market Share, By Rout of Administration 2016-2026 ($Million)
TABLE 34 Spain Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 35 Spain Phenylketonuria Market Share, By Rout of Administration, 2016-2026 ($Million)
TABLE 36 Rest of Western Europe Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 37 Rest of Western Europe Phenylketonuria Market Share, By Rout of Administration, 2016-2026 ($Million)
TABLE 38 Eastern Europe Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 39 Eastern Europe Phenylketonuria Market Share, By Rout of Administration 2016-2026 ($Million)
TABLE 40 Asia-Pacific Phenylketonuria Market Share, By Country, 2016-2026 ($Million)
TABLE 41 Asia-Pacific Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 42 Asia-Pacific Phenylketonuria Market Share, By Rout of Administration, 2016-2026 ($Million)
TABLE 43 Japan Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 44 Japan Phenylketonuria Market Share, By Rout of Administration, 2016-2026 ($Million)
TABLE 45 China Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 46 China Phenylketonuria Market Share, By Rout of Administration, 2016-2026 ($Million)
TABLE 47 Australia Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 48 Australia Phenylketonuria Market Share, By Rout of Administration, 2016-2026 ($Million)
TABLE 49 India Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 50 India Phenylketonuria Market Share, By Rout of Administration, 2016-2026 ($Million)
TABLE 51 South Korea Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 52 South Korea Phenylketonuria Market Share, By Rout of Administration 2016-2026 ($Million)
TABLE 53 Rest of Asia-pacific Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 54 Rest of Asia-pacific Phenylketonuria Market Share, By Rout of Administration, 2016-2026 ($Million)
TABLE 55 The Middle East and Africa Phenylketonuria Market Share, By Region, 2016-2026 ($Million)
TABLE 56 The Middle East and Africa Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 57 The Middle East and Africa Phenylketonuria Market Share, By Rout of Administration, 2016-2026 ($Million)
TABLE 58 The Middle East Phenylketonuria Market Share, By Country, 2016-2026 ($Million)
TABLE 59 The Middle East Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 60 The Middle East Phenylketonuria Market Share, By Rout of Administration, 2016-2026 ($Million)
TABLE 61 Saudi Arabia Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 62 Saudi Arabia Phenylketonuria Market Share, By Rout of Administration, 2016-2026 ($Million)
TABLE 63 UAE Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 64 UAE Phenylketonuria Market Share, By Rout of Administration, 2016-2026 ($Million)
TABLE 65 Qatar Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 66 Qatar Phenylketonuria Market Share, By Rout of Administration, 2016-2026 ($Million)
TABLE 67 Africa Phenylketonuria Market Share, By Country, 2016-2026 ($Million)
TABLE 68 Africa Phenylketonuria Market Share, By Product Type, 2016-2026 ($Million)
TABLE 69 Africa Phenylketonuria Market Share, By Rout of Administration, 2016-2026 ($Million)
List of Figures
FIGURE 1 Phenylketonuria Market Overview
FIGURE 2 Value Chain Analysis
FIGURE 3 Bargaining Power of Suppliers
FIGURE 4 Bargaining Power of Buyers
FIGURE 5 Threat of Substitutes
FIGURE 6 Threat of New Entrants
FIGURE 7 Competitive Rivalry
FIGURE 8 Phenylketonuria Market, 2016-2026
FIGURE 9 U.S. Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 10 Canada Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 11 Mexico Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 12 South America Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 13 Western Europe Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 14 Germany Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 15 France Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 16 UK Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 17 Italy Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 18 Spain Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 19 Rest of Western Europe Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 20 Eastern Europe Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 21 Japan Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 22 China Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 23 Australia Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 24 India Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 25 South Korea Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 26 Rest of Asia-pacific Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 27 The Middle East Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 28 Saudi Arabia Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 29 UAE Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 30 Qatar Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 31 Rest of The Middle East Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 32 Africa Phenylketonuria Market Share, 2016-2026 ($Million)
FIGURE 33 Ambrooke Therapeutics: Revenue Analysis, ($ million)
FIGURE 34 Ambrooke Therapeutics: Segment Revenue 2017 (%)